Comment on: Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children’s Oncology Group AALL1331 trial

Jessica Hochberg; Mitchell S. Cairo

doi:10.3324/haematol.2025.300390

Open access journal of the Ferrata-Storti Foundation, a non-profit organization

Comments

Comment on: Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children’s Oncology Group AALL1331 trial

Jessica Hochberg
Mitchell S. Cairo

Department of Pediatrics

Department of Pediatrics; Department of Pathology; Department of Microbiology and Immunology; Department of Medicine; Department of Cell Biology and Anatomy, New York Medical College, Valhalla, NY

Haematologica Early view Jan 22, 2026 https://doi.org/10.3324/haematol.2025.300390

Abstract

Not available.

Figures & Tables

Article Information

Early view : Comments

DOI

https://doi.org/10.3324/haematol.2025.300390

Published

2026-01-22

Published By

Ferrata Storti Foundation, Pavia, Italy

Print ISSN

0390-6078

Online ISSN

1592-8721

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views

148

PDF Downloads

Statistics from Altmetric.com

No Data

Comment on: Severe toxicity and poor efficacy of reinduction chemotherapy are associated with overall poor outcomes in relapsed B-cell acute lymphoblastic leukemia: a report from the Children’s Oncology Group AALL1331 trial

Abstract

Figures & Tables

Article Information

Article Usage

Statistics from Altmetric.com

Download Citation

Navigate

For Authors

For Reviewers

For Advertisers

Education

Privacy

More